Who owns Proqr Thrapeutics N V shs euro?
- Ticker: PRQR
- CUSIP Number: n71542109
Tip: Access positions for across all investors
Analyze quarterly positions in Proqr Thrapeutics N V shs euro with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Proqr Thrapeutics N V shs euro stock
Who bought or sold Proqr Thrapeutics N V shs euro this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Adage Capital Partners GP | 9.0M | $17M | 44% | Jun 2026 |
|
| Standard Life Aberdeen | 8.9M | $17M | 169% | Jun 2026 |
|
| Affinity Asset Advisors | 5.5M | $10M | 126% | Jun 2026 |
|
| Privium Fund Management B.V. | 5.5M | $10M | 1% | Jun 2026 |
|
| Ikarian Capital | 3.4M | $6.4M | 130% | Jun 2026 |
|
| Woodline Partners | 3.3M | $6.1M | 100% | Jun 2026 |
|
| Heights Capital Management | 2.8M | $5.1M | 100% | Jun 2026 |
|
| Sphera Funds Management | 1.8M | $3.3M | 100% | Jun 2026 |
|
| Kynam Capital Management | 1.6M | $2.9M | 0% | Jun 2026 |
|
| DAFNA Capital Management | 1.5M | $2.8M | -2% | Jun 2026 |
|
| Squadron Capital Management | 1.5M | $2.8M | 100% | Jun 2026 |
|
| 683 Capital Management | 1.4M | $2.6M | 100% | Jun 2026 |
|
| Morgan Stanley | 1.3M | $2.1M | -5% | Mar 2026 |
|
| Citadel Advisors | 1.2M | $2.2M | 68% | Jun 2026 |
|
| Platinum Investment Mangement | 1.2M | $2.2M | -6% | Jun 2026 |
|
| Two Sigma Investments | 1.1M | $2.1M | 24% | Jun 2026 |
|
| Eversept Partners | 1.0M | $1.9M | 100% | Jun 2026 |
|
| Boothbay Fund Management | 949k | $1.8M | 167% | Jun 2026 |
|
| Diadema Partners | 926k | $1.7M | 414% | Jun 2026 |
|
| UBS Group | 639k | $1.2M | 109% | Jun 2026 |
|
| Nomura Asset Management International | 620k | $1.2M | 0% | Jun 2026 |
|
| M28 Capital Management | 600k | $1.1M | 0% | Jun 2026 |
|
| Raymond James Financial | 571k | $1.1M | 5% | Jun 2026 |
|
| Lynx1 Capital Management | 521k | $970k | 661% | Jun 2026 |
|
| Jane Street | 455k | $847k | 1267% | Jun 2026 |
|
| Stempoint Capital | 431k | $802k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 276k | $513k | 60% | Jun 2026 |
|
| Monaco Asset Management SAM | 245k | $455k | -42% | Jun 2026 |
|
| Persistent Asset Partners | 237k | $440k | 413% | Jun 2026 |
|
| Palo Alto Investors | 189k | $351k | 0% | Jun 2026 |
|
| Burkehill Global Management | 176k | $328k | 100% | Jun 2026 |
|
| GSA Capital Partners | 174k | $323k | 52% | Jun 2026 |
|
| Millennium Management | 161k | $300k | -17% | Jun 2026 |
|
| Franklin Street Advisors | 150k | $279k | 0% | Jun 2026 |
|
| Deutsche Bank Aktiengesellschaft | 109k | $202k | 0% | Jun 2026 |
|
| Resources Investment Advisors | 85k | $158k | 0% | Jun 2026 |
|
| Quadrature Capital | 85k | $158k | 605% | Jun 2026 |
|
| RFG Advisory | 64k | $119k | 237% | Jun 2026 |
|
| Bank of America Corporation | 58k | $108k | -69% | Jun 2026 |
|
| Geode Capital Management | 58k | $108k | -32% | Jun 2026 |
|
| Point72 Asset Management | 51k | $94k | -93% | Jun 2026 |
|
| Keating Financial Advisory Services | 48k | $88k | 131% | Jun 2026 |
|
| Velan Capital Investment Management | 45k | $84k | 0% | Jun 2026 |
|
| Guggenheim Capital, LLC Managers | 40k | $74k | 45% | Jun 2026 |
|
| Steward Partners Investment Advisory | 35k | $66k | 2611% | Jun 2026 |
|
| Axiom Investment Management | 31k | $58k | -6% | Jun 2026 |
|
| Moody Lynn & Co/ | 25k | $47k | 0% | Jun 2026 |
|
| JustInvest | 22k | $41k | 14% | Jun 2026 |
|
| Mariner Wealth Advisors | 20k | $38k | 0% | Jun 2026 |
|
| Verdad Advisers | 19k | $36k | 100% | Jun 2026 |
|
| Nano Cap New Millennium Growth Fund | 18k | $33k | 75% | Jun 2026 |
|
| Two Sigma Securities | 16k | $30k | 100% | Jun 2026 |
|
| Atom Investors | 13k | $24k | 0% | Jun 2026 |
|
| China Universal Asset Management | 13k | $23k | -38% | Jun 2026 |
|
| Virtu Financial | 12k | $22k | 100% | Jun 2026 |
|
| Wetzel Investment Advisors | 11k | $20k | 100% | Jun 2026 |
|
| Branch Banking & Trust Company | 10k | $19k | 0% | Jun 2026 |
|
| ADAR1 Capital Management | 10k | $19k | 0% | Jun 2026 |
|
| Wells Fargo & Company | 4.0k | $7.4k | 0% | Jun 2026 |
|
| BlackRock | 3.9k | $7.3k | 0% | Jun 2026 |
|
| Royal Bank of Canada | 3.3k | $6.6k | 973% | Jun 2026 |
|
| Hilton Head Capital Partners | 1.4k | $2.6k | 0% | Jun 2026 |
|
| Farther Finance Advisors | 1.0k | $1.9k | 0% | Jun 2026 |
|
| Mercer Global Advisors | 1.0k | $1.9k | 100% | Jun 2026 |
|
| PFS Partners | 1.0k | $1.9k | 0% | Jun 2026 |
|
| SBI Securities | 515.00 | $958.003000 | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 283.00 | $518.003200 | 100% | Jun 2026 |
|
| Simplex Trading | 271.00 | $504.005800 | -99% | Jun 2026 |
|
| TD Waterhouse Canada | 40.00 | $70.000000 | 0% | Jun 2026 |
|
| Medallion Wealth Advisors | 10.00 | $19.000000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 4.00 | $7.000000 | -97% | Jun 2026 |
|
Who sold out of Proqr Thrapeutics N V shs euro?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sio Capital Management | Mar 2026 | 2.0M | $3.2M |
| Walleye Trading Advisors | Mar 2026 | 608k | $984k |
| Northern Trust | Mar 2026 | 291k | $472k |
| Marshall Wace | Mar 2026 | 116k | $188k |
| Graham Capital Management | Mar 2026 | 92k | $148k |
| XTX Topco | Mar 2026 | 77k | $125k |
| Invesco | Mar 2026 | 45k | $72k |
| Squarepoint Ops | Mar 2026 | 32k | $51k |
| Nine Masts Capital | Mar 2026 | 30k | $48k |
| Susquehanna International | Mar 2026 | 26k | $42k |
| Group One Trading | Mar 2026 | 19k | $31k |